These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 788741)

  • 1. The use of psychotropic drugs: the clinical pharmacologist's view.
    Herxheimer A
    Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):102-3. PubMed ID: 788741
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of new drugs: a clinical pharmacologist's view.
    Breckenridge AM
    Br Med J; 1980 May; 280(6227):1303-5. PubMed ID: 6992929
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence based medicine, RCTs and their natural enemies: the clinical pharmacologist's role.
    Eichler HG
    Int J Clin Pharmacol Ther; 2001 Jan; 39(1):1-3. PubMed ID: 11204931
    [No Abstract]   [Full Text] [Related]  

  • 4. An industrial approach to drug discovery: a pharmacologist's eyeview.
    Armstrong JM; Hicks PE
    Clin Exp Pharmacol Physiol; 1992 Jan; 19(1):51-6. PubMed ID: 1623636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Planning of psychotropic drug trials. Seminar at Jongny, Switzerland, 16-18 March 1977].
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):105-204. PubMed ID: 30097
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of psychotropic drugs].
    Nieto D
    Bol Estud Med Biol; 1974; Suppl 1():309-17. PubMed ID: 4619018
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of scientific models on clinical psychopharmacology: a pharmacologist's view.
    Lasagna L
    Semin Psychiatry; 1972 Aug; 4(3):271-82. PubMed ID: 4680225
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drugs from the pharmacologist's point of view].
    Lembeck F
    Wien Klin Wochenschr; 1970 Nov; 82(46):821-5. PubMed ID: 5521419
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic adverse effects of topical ophthalmological drugs: a clinical pharmacologist's view.
    Eckert GM
    Aust N Z J Ophthalmol; 1985 Feb; 13(1):81-4. PubMed ID: 4015884
    [No Abstract]   [Full Text] [Related]  

  • 10. Not in our methods, but in our ignorance.
    Leber P
    Arch Gen Psychiatry; 2002 Mar; 59(3):279-80. PubMed ID: 11879166
    [No Abstract]   [Full Text] [Related]  

  • 11. Out of the box.
    Gelenberg AJ
    Arch Gen Psychiatry; 2002 Mar; 59(3):281. PubMed ID: 11879167
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ethical and legal problems in first clinical trials of psychotropic drugs (author's transl)].
    Helmchen H
    Arzneimittelforschung; 1978; 28(8):1253-6. PubMed ID: 380572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug information centres: a clinical pharmacologist's view.
    Rawlins MD; Davies DM
    Proc R Soc Med; 1977 Apr; 70(4):252-3. PubMed ID: 866326
    [No Abstract]   [Full Text] [Related]  

  • 14. The loss of serendipity in psychopharmacology.
    Klein DF
    JAMA; 2008 Mar; 299(9):1063-5. PubMed ID: 18319418
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of drugs in general practice.
    Salkind MR
    Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):69-72. PubMed ID: 788742
    [No Abstract]   [Full Text] [Related]  

  • 16. Industry funding and author-industry affiliation in clinical trials in psychiatry.
    Montgomery JH
    Am J Psychiatry; 2006 Jun; 163(6):1110-1; author reply 1111. PubMed ID: 16741218
    [No Abstract]   [Full Text] [Related]  

  • 17. Annual NCDEU Meeting (1982)--abridged proceedings. New Clinical Drug Evaluation Unit, National Institute of Mental Health.
    Psychopharmacol Bull; 1983; 19(1):23-140. PubMed ID: 6338549
    [No Abstract]   [Full Text] [Related]  

  • 18. [Summary of the podium discussion on the fundamentals and guidelines for preliminary clinical trials of psychopharmaceutics (phase I and II) Oct. 29, 1977].
    Heimann H
    Arzneimittelforschung; 1978; 28(9):1534-6. PubMed ID: 383105
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening procedures in volunteers and patients.
    Tyrer PJ
    Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):35-40. PubMed ID: 9957
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rater-specific interference factors in clinical trials (author's transl)].
    Busch H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):152-62. PubMed ID: 360240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.